Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Control of antiviral innate immune response by protein geranylgeranylation.

Yang, Shigao; Harding, Alfred T; Sweeney, Catherine; Miao, David; Swan, Gregory; Zhou, Connie; Jiang, Zhaozhao; Fitzgerald, Katherine A; Hammer, Gianna; Bergo, Martin O; Kroh, Heather K; Lacy, D Borden; Sun, Chunxiang; Glogauer, Michael; Que, Loretta G; Heaton, Nicholas S; Wang, Donghai.
Sci Adv; 5(5): eaav7999, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31149635
The mitochondrial antiviral signaling protein (MAVS) orchestrates host antiviral innate immune response to RNA virus infection. However, how MAVS signaling is controlled to eradicate virus while preventing self-destructive inflammation remains obscure. Here, we show that protein geranylgeranylation, a posttranslational lipid modification of proteins, limits MAVS-mediated immune signaling by targeting Rho family small guanosine triphosphatase Rac1 into the mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) at the mitochondria-ER junction. Protein geranylgeranylation and subsequent palmitoylation promote Rac1 translocation into MAMs upon viral infection. MAM-localized Rac1 limits MAVS' interaction with E3 ligase Trim31 and hence inhibits MAVS ubiquitination, aggregation, and activation. Rac1 also facilitates the recruitment of caspase-8 and cFLIPL to the MAVS signalosome and the subsequent cleavage of Ripk1 that terminates MAVS signaling. Consistently, mice with myeloid deficiency of protein geranylgeranylation showed improved survival upon influenza A virus infection. Our work revealed a critical role of protein geranylgeranylation in regulating antiviral innate immune response.
Selo DaSilva